Effectiveness and utility of hyaluronic acid in osteoarthritis

被引:107
作者
Migliore, Alberto [1 ]
Procopio, Simone [1 ]
机构
[1] Osped S Pietro FBF, Rheumatol Unit, Rome, Italy
关键词
hyaluronic acid; osteoarthritis management; viscosupplementation; intra-articular hyaluronic acid;
D O I
10.11138/ccmbm/2015.12.1.031
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Osteoarthritis (OA) is a chronic degenerative joint disease characterized by pain and progressive functional limitation. Viscosupplementation with intra-articular hyaluronic acid is a treatment option in knee OA that is included in the professional guidelines for treatment of this joint disease, but potentially should apply to all synovial joints in order to reduce pain and improve joint lubrication. Exogenous HA can enhance chondrocyte HA synthesis, prevent the degradation of cartilage and promote its regeneration. Moreover it can reduce the production of proinflammatory mediators and matrix metalloproteinases involved in OA pathogenesis. This mini review highlights the evidence of hyaluronic acid in reducing osteoarthritis symptoms and structural damage, as well as its ability to delay prosthetic surgery. Viscosupplementation should be considered as a long-term therapy.
引用
收藏
页码:31 / 33
页数:3
相关论文
共 29 条
[1]   Final Report of the Safety Assessment of Hyaluronic Acid, Potassium Hyaluronate, and Sodium Hyaluronate [J].
Becker, Lillian C. ;
Bergfeld, Wilma F. ;
Belsito, Donald V. ;
Klaassen, Curtis D. ;
Marks, James G., Jr. ;
Shank, Ronald C. ;
Slaga, Thomas J. ;
Snyder, Paul W. ;
Andersen, F. Alan .
INTERNATIONAL JOURNAL OF TOXICOLOGY, 2009, 28 :5-67
[2]   Osteoarthritis: an update with relevance for clinical practice [J].
Bijlsma, Johannes W. J. ;
Berenbaum, Francis ;
Lafeber, Foris P. J. G. .
LANCET, 2011, 377 (9783) :2115-2126
[3]   Hyaluronan increases RANKL expression in bone marrow strornal cells through CD44 [J].
Cao, JJ ;
Singleton, PA ;
Majumdar, S ;
Boudignon, B ;
Burghardt, A ;
Kurimoto, P ;
Wronski, TJ ;
Bourguignon, LYW ;
Halloran, BP .
JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (01) :30-40
[4]  
Day R, 2004, J RHEUMATOL, V31, P775
[5]   The effect of viscosupplementation on neuromuscular control of the knee in patients with osteoarthritis [J].
Diracoglu, Demirhan ;
Vural, Meltem ;
Baskent, Akin ;
Dikici, Fatih ;
Aksoy, Cihan .
JOURNAL OF BACK AND MUSCULOSKELETAL REHABILITATION, 2009, 22 (01) :1-9
[6]   Use of Viscosupplementation for Knee Osteoarthritis: An Update [J].
Divine, Jon G. ;
Shaffer, Michael D. .
CURRENT SPORTS MEDICINE REPORTS, 2011, 10 (05) :279-284
[7]  
Dougados M, 1993, Osteoarthritis Cartilage, V1, P97, DOI 10.1016/S1063-4584(05)80024-X
[8]  
Dougados M, 2011, RHEUMATOLOGY
[9]  
Frizziero L, 1998, CLIN EXP RHEUMATOL, V16, P441
[10]   Morphological analysis of articular cartilage biopsies from a randomized. clinical study comparing the effects of 500-730 kDa sodium hyaluronate (Hyalgan®) and methylprednisolone acetate on primary osteoarthritis of the knee [J].
Guidolin, DD ;
Ronchetti, IP ;
Lini, E ;
Guerra, D ;
Frizziero, L .
OSTEOARTHRITIS AND CARTILAGE, 2001, 9 (04) :371-381